Phibro Animal Health (PAHC) Declares $0.12 Quarterly Dividend; 2.3% Yield
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Phibro Animal Health (PAHC) Tops Q1 EPS by 7c, Revenues Beat; Offers 2Q Revenue Guidance Below Consensus, 2Q EPS Mid-Point Guidance Below Consensus
February 3, 2021 4:48 PM ESTPhibro Animal Health (NASDAQ: PAHC) reported Q1 EPS of $0.34, $0.07 better than the analyst estimate of $0.27. Revenue for the quarter came in at $206 million versus the consensus estimate of $205.48 million.
Highlights for the December 31, 2020 quarter (compared to the quarter ended December 31, 2019)
Net sales of $206 million, a decrease of $8 million, or 4%Net income of $13 million, an increase of $1 million, or 8%Diluted EPS of $0.32, an increase of $0.03, or 10%.Adjusted EBITDA of $29... More